Virtual Screening of FDA Approved Drugs Library to Identify a Potential Inhibitor against NS2B-NS3 Protease of Yellow Fever Virus
Hasanain Abdulhameed Odhar, Salam Waheed Ahjel, Ali A. Mohammed Ali Albeer, Ahmed Fadhil Hashim & Suhad Sami Humadi · Journal of Pharmaceutical Research International · 2021
Yellow fever is a neglected hemorrhagic disease with a high case fatality rate ranging between 25% and 50% for the hospitalized patients. Yellow fever disease is caused by a zoonotic pathogen known as yellow fever virus. This RNA virus is usually transmitted by mosquitos and it i...
Open access
Research Article
10.9734/jpri/2021/v33i51B33528